• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of risk communication on patient's safety during the pandemic.疫情期间风险沟通对患者安全的影响。
Ther Adv Drug Saf. 2023 Mar 17;14:20420986231159752. doi: 10.1177/20420986231159752. eCollection 2023.
2
Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation.管理新冠疫情信息疫情的框架:世卫组织在线众包技术磋商会的方法与结果
J Med Internet Res. 2020 Jun 26;22(6):e19659. doi: 10.2196/19659.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
A Public Health Research Agenda for Managing Infodemics: Methods and Results of the First WHO Infodemiology Conference.应对信息疫情的公共卫生研究议程:首届世界卫生组织信息流行病学会议的方法与成果
JMIR Infodemiology. 2021 Sep 15;1(1):e30979. doi: 10.2196/30979. eCollection 2021 Jan-Dec.
5
Risk communication on vaccines during the COVID19 pandemic: is there room for small size or private initiatives? An Israeli experience.新冠疫情期间关于疫苗的风险沟通:小型或私人举措是否有空间?以色列的经验。
Ther Adv Drug Saf. 2022 Aug 5;13:20420986221112189. doi: 10.1177/20420986221112189. eCollection 2022.
6
Return-to-work, disabilities and occupational health in the age of COVID-19.新冠疫情时代的重返工作岗位、残疾与职业健康。
Scand J Work Environ Health. 2021 Jul 1;47(5):408-409. doi: 10.5271/sjweh.3960. Epub 2021 May 18.
7
Tuberculosis结核病
8
A Reminder of Skin Cancer During the COVID-19 Pandemic.新冠疫情期间对皮肤癌的提醒。
Acta Dermatovenerol Croat. 2021 Apr;291(1):58.
9
Lessons Learned From , a Social Media-Based Science Communication Project Targeting the COVID-19 Infodemic.从基于社交媒体的科学传播项目(针对 COVID-19 信息疫情)中吸取的教训。
Public Health Rep. 2022 May-Jun;137(3):449-456. doi: 10.1177/00333549221076544. Epub 2022 Mar 3.
10
Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.新型冠状病毒(COVID-19)大流行的临床洞察系统评价:美国农村人口的持续挑战。
Int J Environ Res Public Health. 2020 Jun 15;17(12):4279. doi: 10.3390/ijerph17124279.

引用本文的文献

1
Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts.马来西亚药品风险沟通策略:跨国专家德尔菲研究。
BMC Health Serv Res. 2024 Sep 3;24(1):1019. doi: 10.1186/s12913-024-11476-0.
2
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance.在信息疫情时代加强自我药疗行为:药物警戒的作用
Ther Adv Drug Saf. 2023 Aug 23;14:20420986231194754. doi: 10.1177/20420986231194754. eCollection 2023.

本文引用的文献

1
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge.2019冠状病毒病疫苗的全球安全性监测:药物警戒如何应对挑战
Ther Adv Drug Saf. 2022 Aug 25;13:20420986221118972. doi: 10.1177/20420986221118972. eCollection 2022.
2
A Deadly Infodemic: Social Media and the Power of COVID-19 Misinformation.致命的信息疫情:社交媒体与新冠病毒错误信息的力量。
J Med Internet Res. 2022 Feb 1;24(2):e35552. doi: 10.2196/35552.
3
A Public Health Research Agenda for Managing Infodemics: Methods and Results of the First WHO Infodemiology Conference.应对信息疫情的公共卫生研究议程:首届世界卫生组织信息流行病学会议的方法与成果
JMIR Infodemiology. 2021 Sep 15;1(1):e30979. doi: 10.2196/30979. eCollection 2021 Jan-Dec.
4
Factors influencing COVID-19 vaccination intention: The roles of vaccine knowledge, vaccine risk perception, and doctor-patient communication.影响 COVID-19 疫苗接种意愿的因素:疫苗知识、疫苗风险感知和医患沟通的作用。
Patient Educ Couns. 2022 Feb;105(2):277-283. doi: 10.1016/j.pec.2021.09.023. Epub 2021 Sep 20.
5
The health belief model: How public health can address the misinformation crisis beyond COVID-19.健康信念模型:公共卫生如何应对新冠疫情之外的错误信息危机。
Public Health Pract (Oxf). 2021 Nov;2:100151. doi: 10.1016/j.puhip.2021.100151. Epub 2021 Jun 8.
6
[Statistical literacy and risk communication for COVID-19 vaccination: a scoping reviewLiteracia estatística e comunicação de risco para a vacinação contra a COVID-19: revisão de escopo].[COVID-19疫苗接种的统计素养与风险沟通:一项范围综述 关于COVID-19疫苗接种的统计素养与风险沟通:范围综述]
Rev Panam Salud Publica. 2021 Aug 31;45:e108. doi: 10.26633/RPSP.2021.108. eCollection 2021.
7
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions.新冠疫苗接种的促进因素和障碍:一项国际认知和意愿研究。
Vaccine. 2021 Aug 23;39(36):5116-5128. doi: 10.1016/j.vaccine.2021.07.056. Epub 2021 Jul 23.
8
Understanding COVID-19 vaccine hesitancy.理解对新冠疫苗的犹豫态度。
Nat Med. 2021 Aug;27(8):1338-1339. doi: 10.1038/s41591-021-01459-7.
9
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.新冠病毒疫苗在中低收入国家的接受程度和犹豫。
Nat Med. 2021 Aug;27(8):1385-1394. doi: 10.1038/s41591-021-01454-y. Epub 2021 Jul 16.
10
Communicating with patients and the public about COVID-19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation.就2019冠状病毒病疫苗安全性与患者及公众进行沟通:社会科学与免疫合作组织的建议
Med J Aust. 2021 Jul;215(1):9-12.e1. doi: 10.5694/mja2.51136. Epub 2021 Jun 16.

疫情期间风险沟通对患者安全的影响。

Impact of risk communication on patient's safety during the pandemic.

作者信息

Zuluaga-Arias Heyde-Patricia, Alkhakany Mayada, Younus Manal M, Sefiani Houda, Caro-Rojas Angela, Al-Zubiedi Sameh, Albalawi Wafi F, Alshammari Thamir M

机构信息

Colombian Association of Pharmacovigilance, Bogotá, Colombia.

International Society of Pharmacovigilance - LATAM Chapter, Bogotá, Colombia.

出版信息

Ther Adv Drug Saf. 2023 Mar 17;14:20420986231159752. doi: 10.1177/20420986231159752. eCollection 2023.

DOI:10.1177/20420986231159752
PMID:36949767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10026095/
Abstract

UNLABELLED

More than 2 years has passed since the pandemic was declared in 2019 due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was later declared to be the pathogen causing coronavirus disease 2019 (COVID-19). During this time, many healthcare systems faced numerous challenges to control the high morbidity and mortality of the disease. Unlike previous pandemics, the actions against this pandemic started quickly on both the global and country levels. These actions were, scientifically, to study the virus as well as transmission process and to develop medications and vaccines against it. Also, we had to protect people from transmission by knowing how best to apply precautionary methods. However, there were some unexpected negative consequences of the pandemic and one of those the World Health Organization (WHO) called 'infodemic'. This term infodemic refers to the manipulation of a population's behavior in the assessment of information (or, more accurately, lack of assessment) related to the use of medications, particularly vaccines. Unfortunately, even with positive development in science, there was limited and often contradictory amount of information on the safety and efficacy profile of drugs and vaccines. Therefore, this made it harder for public health agencies to determine the impact of the incidence of adverse reactions and events associated with interventions such as vaccines. Hence, risk communication needs to be emphasized during any pandemic, as ignoring risk communications to different stakeholders could undermine all well-intended therapeutic interventions. Given this, it is important that the different stakeholders involved (health authorities, societies, healthcare professionals, etc.) assess the different behavioral patterns within their respective populations and propose appropriate strategies to act. Such an approach complement having risk management and communication plans for this and future pandemics. The aim of this article is to explore how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future.

PLAIN LANGUAGE SUMMARY

More than 2 years have gone by since the pandemic was declared in 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many challenges have been confronted by the healthcare system during this time to control the high impact of this disease. This pandemic, unlike others that humanity has faced, is characterized by a special feature: today, we have an enormous amount of information only a click away. This situation has been of great benefit to humanity and has allowed the development of science; nevertheless, misinformation (infodemics) has been a major problem, which has revealed the behavior of the population regarding the evaluation of information (or better, lack of assessment) related to the use of medications and particularly of vaccines. Given this, it is important that the different people involved (health authorities, societies, healthcare professionals, etc.) assess the behavior and propose appropriate strategies to act and have plans for this and future pandemics. This article intends to explore from the authors' perspective how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future.

摘要

无标签

自2019年因严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宣布大流行以来,已经过去了两年多,该病毒后来被宣布为导致2019冠状病毒病(COVID-19)的病原体。在此期间,许多医疗系统在控制该疾病的高发病率和死亡率方面面临诸多挑战。与以往的大流行不同,针对此次大流行的行动在全球和国家层面迅速展开。从科学角度来看,这些行动包括研究病毒及其传播过程,以及研发针对它的药物和疫苗。此外,我们还必须通过了解如何最好地应用预防方法来保护人们免受传播。然而,这场大流行产生了一些意想不到的负面后果,其中之一就是世界卫生组织(WHO)所称的“信息疫情”。“信息疫情”一词指的是在评估与药物特别是疫苗使用相关的信息(或者更准确地说,缺乏评估)时对人群行为的操纵。不幸的是,即使科学有了积极进展,关于药物和疫苗安全性及有效性的信息数量有限且往往相互矛盾。因此,这使得公共卫生机构更难确定与疫苗等干预措施相关的不良反应和事件发生率的影响。因此,在任何大流行期间都需要强调风险沟通,因为忽视与不同利益相关者的风险沟通可能会破坏所有善意的治疗干预措施。鉴于此,重要的是,所涉及的不同利益相关者(卫生当局、社会、医疗保健专业人员等)评估其各自人群中的不同行为模式,并提出适当的行动策略。这种方法补充了针对此次及未来大流行的风险管理和沟通计划。本文的目的是探讨大流行期间的信息管理、风险管理和风险沟通如何能为未来提供宝贵经验教训。

通俗易懂的总结

自2019年因严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宣布大流行以来,已经过去了两年多。在此期间,医疗系统面临诸多挑战以控制这种疾病的高影响。与人类面临的其他大流行不同,此次大流行有一个特殊特征:如今,我们只需点击一下就能获取大量信息。这种情况对人类大有裨益,并推动了科学发展;然而,错误信息(信息疫情)一直是个大问题,它揭示了人群在评估与药物特别是疫苗使用相关的信息(或者更确切地说,缺乏评估)时的行为。鉴于此,重要的是,所涉及的不同人群(卫生当局、社会、医疗保健专业人员等)评估行为并提出适当的行动策略,以及针对此次及未来大流行制定计划。本文旨在从作者的角度探讨大流行期间的信息管理、风险管理和风险沟通如何能为未来提供宝贵经验教训。